We recently published 10 Firms Stealing the Show on Wall Street. Almonty Industries Inc. (NASDAQ:ALM) is one of the best performers on Thursday. Almonty Industries jumped by 6.64 percent on Thursday to close at $8.35 apiece as investors loaded portfolios ahead of the looming start of commercial operations of its mine site in South Korea. In a statement earlier this week, Almonty Industries Inc. (NASDAQ:ALM) said that it has successfully delivered the first truckload of ore to the Run-of-Mine pad at the S ...

In line with market sentiment and Wall Street vision, we think that it is reasonable that investors include shares of Almonty Industries Inc. ( ALM ), a NASDAQ-listed company, in theirAlberto holds a Master's degree in Business Economics. During his academic career he acquired an extensive managerial and economic background, with a solid quantitative basis. He covers all sectors and the different types of stocks. Essentially describes a useful investment strategy that fits the profile of any investor, wheth ...

TORONTO--(BUSINESS WIRE)--Almonty Industries Inc. ("Almonty†or the "Company") (NASDAQ: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1), a leading global producer of tungsten, today announced the first truckload of ore has been successfully delivered to the ROM (Run-of-Mine) pad at the Sangdong Mine, a pivotal transition from early-stage mine development to active mining operations and the final step before commencement of commercial production. Lewis Black, President and Chief Executive Officer, said: "This fi ...

Group 1 - The market for critical minerals has shifted from a basic commodity model to one focused on national security and supply chain reliability [1] - There is a growing emphasis on identifying companies with strong brand recognition, solid financials, and growth potential within the consumer products sector [1] - Understanding consumer trends is crucial for identifying profitable investment opportunities in the industry [1]

Group 1 - U.S. stocks experienced a decline, with the Nasdaq Composite dropping over 100 points on Monday [1] - Kyverna Therapeutics Inc shares surged 31% to $11.49 following the announcement of topline data from the KYSA-8 Phase 2 trial [2][3] - The KYSA-8 trial involved mivocabtagene autoleucel (miv-cel), a CAR T-cell therapy targeting stiff person syndrome [1] Group 2 - Other notable stock gains included Beneficient, which increased by 29.3% to $6.21, and Immunome Inc, which rose 25.5% to $24.56 after positive results from its Phase 3 trial [3] - Falcon's Beyond Global Inc gained 14% to $12.83, while XBP Global Holdings Inc surged 11.5% to $6.39 [3] - Almonty Industries Inc announced a voluntary withdrawal of its base shelf prospectus, leading to a 9.1% increase in its stock price to $7.38 [3]

TORONTO--(BUSINESS WIRE)--Almonty Industries Inc. ("Almonty†or the "Company") (NASDAQ: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1), a leading global producer of tungsten concentrate, announced today the closing of its previously announced upsized underwritten offering of common shares (the "Common Shares†), including the full exercise of the underwriters' over-allotment option (the "Over-Allotment Option†), for aggregate gross proceeds of US$129,375,000 (the "Offering†). The syndicate of unde. ...

TORONTO--(BUSINESS WIRE)--Almonty Industries Inc. ("Almonty†or the "Company") (NASDAQ: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1), a leading global producer of tungsten concentrate, announced today the closing of its previously announced upsized underwritten offering of common shares (the "Common Shares†), including the full exercise of the underwriters' over-allotment option (the "Over-Allotment Option†), for aggregate gross proceeds of US$129,375,000 (the "Offering†). The syndicate of unde. ...

Core Insights - U.S. stock futures showed mixed results, with Dow futures up approximately 0.1% [1] - Toll Brothers Inc reported mixed financial results for Q4 fiscal 2025, leading to a sharp decline in its stock price [1] Toll Brothers Inc - The company reported Q4 revenue of $3.42 billion, surpassing the consensus estimate of $3.30 billion [2] - Q4 earnings were $4.58 per share, which fell short of analyst expectations of $4.89 per share [2] - Following the earnings report, Toll Brothers shares decreased by 3.5% to $131.45 in pre-market trading [2] Other Stocks - Almonty Industries Inc saw a 14.2% drop to $6.78 after announcing a $112.5 million underwritten offering [3] - Cemtrex Inc's shares fell 11.4% to $6.25 after a significant surge of 130% on the previous day [3] - Fulcrum Therapeutics, Inc. experienced a 4.9% decline to $12.35 following a proposed $150 million public offering [3] - Graphic Packaging Holding Company shares decreased by 4.2% to $14.93 after appointing a new CEO and announcing optimization initiatives [3] - Baidu, Inc. shares fell 3.8% to $125.05 after a prior gain of over 3% [3] - SLM Corporation's stock dropped 3.5% to $29.77 in pre-market trading [3] - MINISO Group Holding Limited shares decreased by 2.3% to $19.46 after a previous increase of over 3% [3]

Core Viewpoint - Almonty Industries Inc. has announced an upsized underwritten offering of common shares, aiming to raise significant capital through the sale of shares at a set price [1] Group 1: Offering Details - The company is offering 18,000,000 common shares at a public offering price of US$6.25 per share [1] - The total gross proceeds from this offering are expected to be US$112,500,000 [1] Group 2: Underwriters - Almonty has granted the underwriters certain options related to the offering, although specific details on these options are not provided in the excerpt [1]

TORONTO--(BUSINESS WIRE)--Almonty Industries Inc. ("Almonty†or the "Company") (NASDAQ: ALM) (TSX: AII) (ASX: AII) (Frankfurt: ALI1), a leading global producer of tungsten concentrate, announced today the filing of a preliminary prospectus supplement (the "Supplement†) to its short form base shelf prospectus dated October 31, 2025 (the "Base Prospectus†), in connection with a proposed public offering of 15 million of Almonty's common shares ("Common Shares†) in the United States (the "Offering†. ...